19 June 2013
Keywords: astrazeneca, submits, snda, merrem, iv, submitted, supplemental
Article | 09 August 2004
AstraZeneca has submitted a supplemental New Drug Application with theUS Food and Drug Administration, seeking approval for a new indication
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 August 2004
2 August 2004
16 August 2004
© 2013 thepharmaletter.com